Pancreatic cancer cells with activated TGFβ induce angiogenesis when implanted into mice [121] whilst TGFβ-blocking antibodies or targeted deletion of TGFβ in mice results in decreased angiogenesis [122]. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.